These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 23010362)

  • 1. Functional and structural interaction of (-)-reboxetine with the human α4β2 nicotinic acetylcholine receptor.
    Arias HR; Fedorov NB; Benson LC; Lippiello PM; Gatto GJ; Feuerbach D; Ortells MO
    J Pharmacol Exp Ther; 2013 Jan; 344(1):113-23. PubMed ID: 23010362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. (-)-Reboxetine inhibits muscle nicotinic acetylcholine receptors by interacting with luminal and non-luminal sites.
    Arias HR; Ortells MO; Feuerbach D
    Neurochem Int; 2013 Nov; 63(5):423-31. PubMed ID: 23917086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological and molecular studies on the interaction of varenicline with different nicotinic acetylcholine receptor subtypes. Potential mechanism underlying partial agonism at human α4β2 and α3β4 subtypes.
    Arias HR; Feuerbach D; Targowska-Duda K; Kaczor AA; Poso A; Jozwiak K
    Biochim Biophys Acta; 2015 Feb; 1848(2):731-41. PubMed ID: 25475645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different interaction between tricyclic antidepressants and mecamylamine with the human alpha3beta4 nicotinic acetylcholine receptor ion channel.
    Arias HR; Targowska-Duda KM; Feuerbach D; Sullivan CJ; Maciejewski R; Jozwiak K
    Neurochem Int; 2010 Mar; 56(4):642-9. PubMed ID: 20117161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel 2-(substituted benzyl)quinuclidines inhibit human α7 and α4β2 nicotinic receptors by different mechanisms.
    Arias HR; López JJ; Feuerbach D; Fierro A; Ortells MO; Pérez EG
    Int J Biochem Cell Biol; 2013 Nov; 45(11):2420-30. PubMed ID: 23954208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tricyclic antidepressants and mecamylamine bind to different sites in the human alpha4beta2 nicotinic receptor ion channel.
    Arias HR; Rosenberg A; Targowska-Duda KM; Feuerbach D; Jozwiak K; Moaddel R; Wainer IW
    Int J Biochem Cell Biol; 2010 Jun; 42(6):1007-18. PubMed ID: 20223294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roles of nicotinic acetylcholine receptor beta subunits in function of human alpha4-containing nicotinic receptors.
    Wu J; Liu Q; Yu K; Hu J; Kuo YP; Segerberg M; St John PA; Lukas RJ
    J Physiol; 2006 Oct; 576(Pt 1):103-18. PubMed ID: 16825297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iptakalim as a human nicotinic acetylcholine receptor antagonist.
    Hu J; Lindenberger K; Hu G; Wang H; Lukas RJ; Wu J
    J Pharmacol Exp Ther; 2006 Feb; 316(2):914-25. PubMed ID: 16223869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-activity relationship of ibogaine analogs interacting with nicotinic acetylcholine receptors in different conformational states.
    Arias HR; Feuerbach D; Targowska-Duda KM; Jozwiak K
    Int J Biochem Cell Biol; 2011 Sep; 43(9):1330-9. PubMed ID: 21642011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A robust homogeneous binding assay for alpha4beta2 nicotinic acetylcholine receptor.
    Hui X; Gao J; Xie X; Suto N; Ogiku T; Wang MW
    Acta Pharmacol Sin; 2005 Oct; 26(10):1175-80. PubMed ID: 16174432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ABT-594 [(R)-5-(2-azetidinylmethoxy)-2-chloropyridine]: a novel, orally effective analgesic acting via neuronal nicotinic acetylcholine receptors: I. In vitro characterization.
    Donnelly-Roberts DL; Puttfarcken PS; Kuntzweiler TA; Briggs CA; Anderson DJ; Campbell JE; Piattoni-Kaplan M; McKenna DG; Wasicak JT; Holladay MW; Williams M; Arneric SP
    J Pharmacol Exp Ther; 1998 May; 285(2):777-86. PubMed ID: 9580626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selectivity of (±)-citalopram at nicotinic acetylcholine receptors and different inhibitory mechanisms between habenular α3β4* and α9α10 subtypes.
    Arias HR; Jin XT; Gallino S; Peng C; Feuerbach D; García-Colunga J; Elgoyhen AB; Drenan RM; Ortells MO
    Neurochem Int; 2019 Dec; 131():104552. PubMed ID: 31545995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Engineered α4β2 nicotinic acetylcholine receptors as models for measuring agonist binding and effect at the orthosteric low-affinity α4-α4 interface.
    Ahring PK; Olsen JA; Nielsen EØ; Peters D; Pedersen MH; Rohde LA; Kastrup JS; Shahsavar A; Indurthi DC; Chebib M; Gajhede M; Balle T
    Neuropharmacology; 2015 May; 92():135-45. PubMed ID: 25595102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Agonist-induced hump current production in heterologously-expressed human alpha4beta2-nicotinic acetylcholine receptors.
    Liu Q; Yu KW; Chang YC; Lukas RJ; Wu J
    Acta Pharmacol Sin; 2008 Mar; 29(3):305-19. PubMed ID: 18298895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of bupropion with muscle-type nicotinic acetylcholine receptors in different conformational states.
    Arias HR; Gumilar F; Rosenberg A; Targowska-Duda KM; Feuerbach D; Jozwiak K; Moaddel R; Wainer IW; Bouzat C
    Biochemistry; 2009 Jun; 48(21):4506-18. PubMed ID: 19334677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional characterization of mouse alpha4beta2 nicotinic acetylcholine receptors stably expressed in HEK293T cells.
    Karadsheh MS; Shah MS; Tang X; Macdonald RL; Stitzel JA
    J Neurochem; 2004 Dec; 91(5):1138-50. PubMed ID: 15569257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methadone is a non-competitive antagonist at the α4β2 and α3* nicotinic acetylcholine receptors and an agonist at the α7 nicotinic acetylcholine receptor.
    Talka R; Salminen O; Tuominen RK
    Basic Clin Pharmacol Toxicol; 2015 Apr; 116(4):321-8. PubMed ID: 25196810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study of the calcium dynamics of the human alpha4beta2, alpha3beta4 and alpha1beta1gammadelta nicotinic acetylcholine receptors.
    Michelmore S; Croskery K; Nozulak J; Hoyer D; Longato R; Weber A; Bouhelal R; Feuerbach D
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Sep; 366(3):235-45. PubMed ID: 12172706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subtype-selective nicotinic acetylcholine receptor agonists enhance the responsiveness to citalopram and reboxetine in the mouse forced swim test.
    Andreasen JT; Nielsen EØ; Christensen JK; Olsen GM; Peters D; Mirza NR; Redrobe JP
    J Psychopharmacol; 2011 Oct; 25(10):1347-56. PubMed ID: 20360159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. beta-Amyloid directly inhibits human alpha4beta2-nicotinic acetylcholine receptors heterologously expressed in human SH-EP1 cells.
    Wu J; Kuo YP; George AA; Xu L; Hu J; Lukas RJ
    J Biol Chem; 2004 Sep; 279(36):37842-51. PubMed ID: 15234980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.